Snow GB - Search Results

1

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

Börjesson PK, Postema EJ, Roos JC, Colnot DR, Marres HA, van Schie MH, Stehle G, de Bree R, Snow GB, Oyen WJ, van Dongen GA. Börjesson PK, et al. Among authors: snow gb. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3961S-72S. Clin Cancer Res. 2003. PMID: 14506195 Clinical Trial.

2

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.

Braakhuis BJ, van Dongen GA, Vermorken JB, Snow GB. Braakhuis BJ, et al. Among authors: snow gb. Cancer Res. 1991 Jan 1;51(1):211-4. Cancer Res. 1991. PMID: 1988086

3

Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.

de Bree R, Roos JC, Quak JJ, den Hollander W, van den Brekel MW, van der Wal JE, Tobi H, Snow GB, van Dongen GA. de Bree R, et al. Among authors: snow gb. J Nucl Med. 1994 May;35(5):775-83. J Nucl Med. 1994. PMID: 8176458 Free article.

4

186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.

Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: snow gb. Cancer Res. 1993 Aug 1;53(15):3524-9. Cancer Res. 1993. PMID: 8339258

5

MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.

Schrijvers AH, Quak JJ, Uyterlinde AM, van Walsum M, Meijer CJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Among authors: snow gb. Cancer Res. 1993 Sep 15;53(18):4383-90. Cancer Res. 1993. PMID: 8364934

6

Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.

van Dongen GA, Brakenhoff RM, ten Brink CT, van Gog FB, de Bree R, Quak JJ, Snow GB. van Dongen GA, et al. Among authors: snow gb. Anticancer Res. 1996 Jul-Aug;16(4C):2409-13. Anticancer Res. 1996. PMID: 8816843 Review.

7

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.

de Bree R, Roos JC, Plaizier MA, Quak JJ, van Kamp GJ, den Hollander W, Snow GB, van Dongen GA. de Bree R, et al. Among authors: snow gb. Br J Cancer. 1997;75(7):1049-60. doi: 10.1038/bjc.1997.179. Br J Cancer. 1997. PMID: 9083342 Free PMC article.

8

High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.

van Gog FB, Visser GW, Stroomer JW, Roos JC, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: snow gb. Cancer. 1997 Dec 15;80(12 Suppl):2360-70. Cancer. 1997. PMID: 9406684

9

Prospects for future studies in head and neck cancer.

van Dongen GA, Snow GB. van Dongen GA, et al. Among authors: snow gb. Eur J Surg Oncol. 1997 Dec;23(6):486-91. doi: 10.1016/s0748-7983(97)92789-x. Eur J Surg Oncol. 1997. PMID: 9484916 Review.

10

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.

van Gog FB, Brakenhoff RH, Stigter-van Walsum M, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: snow gb. Int J Cancer. 1998 Jul 3;77(1):13-8. doi: 10.1002/(sici)1097-0215(19980703)77:1<13::aid-ijc3>3.0.co;2-2. Int J Cancer. 1998. PMID: 9639387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters